Non-interventional, Multi-Centre, Post-Authorisation Safety Study With Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Turoctocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 05 Feb 2018 Planned initiation date changed from 5 Dec 2017 to 5 Mar 2018.
- 02 Oct 2017 Planned initiation date changed from 15 Jun 2017 to 5 Dec 2017.
- 09 Jun 2017 New trial record